From Pulse 2.0 · Amit Chowdhry · · 40s
PAI Pharma Acquires Nexus for Hospital Products
PAI Pharma adds 20+ hospital injectables via Nexus acquisition.
In brief
PAI Pharma adds 20+ hospital injectables via Nexus acquisition. PAI Pharma acquired Nexus Pharmaceuticals to expand its hospital injectable product portfolio. Originally reported by Pulse 2.0.
PAI Pharma Acquires Nexus
PAI Pharma has acquired Nexus Pharmaceuticals, expanding its portfolio of injectable medicines used in critical care, oncology and other hospital settings.
Adds 20+ Hospital Products
The transaction adds more than 20 commercial hospital injectable products, customer relationships and development expertise to PAI’s growing sterile pharmaceutical business.
Complementary Capabilities
Nexus specializes in complex injectable products, including therapies that have historically experienced supply shortages, complementing PAI’s ready-to-dose oral liquid products.
At a glance
PAI Pharma acquired Nexus Pharmaceuticals to expand its hospital injectable product portfolio.
